No Data
Why SMO ClinPlusLTD's (SZSE:301257) Shaky Earnings Are Just The Beginning Of Its Problems
Prius: First Quarter Report 2025
Prius: 2024 Annual Report Summary
Prius: 2024 Annual Report
Purice (301257.SZ): In the first quarter, the net income was 7.4316 million yuan, a decrease of 67.32% year-on-year.
On April 28, Gelonghui reported that Puris (301257.SZ) announced its 2025 first-quarter report, achieving revenue of 0.176 billion yuan, a decrease of 4.37% year-on-year; the Net income attributable to shareholders of the listed company is 7.4316 million yuan, down 67.32% year-on-year; the Net income attributable to shareholders of the listed company after deducting non-recurring gains and losses is 4.8264 million yuan, a decrease of 75.34% year-on-year; the EPS is 0.09 yuan.
Puris (301257.SZ): The actual controller Lai Chunbao has accumulated a Shareholding of 0.0545 million shares.
On April 15, Gelonghui reported that Prise (301257.SZ) announced that as of the disclosure date of the announcement, the shareholding plan of the actual controller and Chairman, Mr. Lai Chunbao, has surpassed the halfway point. From January 15, 2025, to April 15, 2025, Mr. Lai Chunbao has cumulatively increased his shareholding in the company by 0.0545 million shares through the centralized bidding method via the Shenzhen Stock Exchange trading system, accounting for 0.07% of the company's total equity, with a total investment of 1.6768 million yuan (excluding transaction fees).
Is SMO ClinPlus CO.,LTD.'s (SZSE:301257) Recent Stock Performance Tethered To Its Strong Fundamentals?